These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26999988)

  • 1. Early Onset Dapsone-induced Photosensitive Dermatitis: A Rare Side Effect of a Common Drug.
    Karjigi S; Murthy SC; Kallappa H; Kusuma MR; Reddy YN
    Indian J Lepr; 2015; 87(3):161-4. PubMed ID: 26999988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapsone induced acute photosensitivity dermatitis; a case report and review of literature.
    De D; Dogra S; Kaur I
    Lepr Rev; 2007 Dec; 78(4):401-4. PubMed ID: 18309716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone-induced photosensitivity: a rare clinical presentation.
    Kar BR
    Photodermatol Photoimmunol Photomed; 2008 Oct; 24(5):270-1. PubMed ID: 18811870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone agranulocytosis in a leprosy patient.
    Hiran S; Pande TK; Pani S; Vishwanathan KA
    Lepr Rev; 1994 Sep; 65(3):279-81. PubMed ID: 8942159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lethal case of the dapsone hypersensitivity syndrome involving the myocardium.
    Hoogeveen RM; van der Bom T; de Boer HH; Thurlings RM; Wind BS; de Vries HJ; van Lent AU; Beuers U; van der Wal AC; Nellen FJ
    Neth J Med; 2016 Feb; 74(2):89-92. PubMed ID: 26951355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative procedure to allow continuation of dapsone therapy despite serious adverse reaction in a case of dapsone-sensitive erythema elevatum diutinum.
    Seneschal J; Guillet S; Ezzedine K; Taïeb A; Milpied B
    Dermatology; 2012; 224(2):115-9. PubMed ID: 22508198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
    Ranawaka RR; Mendis S; Weerakoon HS
    Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report.
    Gavilanes MC; Palacio AL; Chellini PR; Nery JA; Rego JG
    Lepr Rev; 2015 Jun; 86(2):186-90. PubMed ID: 26502691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia.
    Ashurst JV; Wasson MN; Hauger W; Fritz WT
    J Am Osteopath Assoc; 2010 Jan; 110(1):16-20. PubMed ID: 20093649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone-induced motor peripheral neuropathy in pemphigus foliaceus.
    Rhodes LE; Coleman MD; Lewis-Jones MS
    Clin Exp Dermatol; 1995 Mar; 20(2):155-6. PubMed ID: 8565254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone-induced motor polyneuropathy in a patient with leprosy.
    Pavithran K; Satish TC
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):262-3. PubMed ID: 9251603
    [No Abstract]   [Full Text] [Related]  

  • 13. Borderline tuberculoid leprosy in childhood onset systemic lupus erythematosus patient.
    Lopes VA; Lourenço DM; Guariento A; Trindade MA; Avancini J; Silva CA
    Lupus; 2015 Nov; 24(13):1448-51. PubMed ID: 26113359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dapsone: An Update.
    Karjigi S; Murthy SC; Kallappa H; Kusuma MR; Aruna B; Reddy YN
    Indian J Lepr; 2016 Sep; 87(4):233-239. PubMed ID: 29762952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone-induced methemoglobinemia in leprosy patients.
    Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy.
    Balagon MF; Cellona RV; Abalos RM; Gelber RH; Saunderson PR
    Lepr Rev; 2010 Mar; 81(1):27-33. PubMed ID: 20496567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone-induced agranulocytosis in a patient of leprosy.
    Mishra M; Chhetia R
    Indian J Dermatol Venereol Leprol; 2006; 72(6):456-7. PubMed ID: 17179627
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal hypersensitivity vasculitis associated with dapsone.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Rabel-Filho OC; Martini-Filho D; Fontes CJ
    Am J Kidney Dis; 2005 Oct; 46(4):e51-3. PubMed ID: 16183407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone syndrome in cutaneous lupus erythematosus.
    Mok CC; Lau CS
    J Rheumatol; 1996 Apr; 23(4):766-8. PubMed ID: 8730143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.